Batol, Jenalyn .

HRN: 10-50-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/14/2025
12/15/2025
IV
500mg
Now
For Cs
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: